Abbott’s next-gen Oncodetect molecular residual disease (MRD) test detects traces of circulating tumor DNA in a patient’s ...
The test's detection limit improves 30-fold, to below one part per million under high-end inputs; it has not been cleared or ...
Abbott Laboratories remains a Buy, driven by robust device and diagnostics growth and the strategic spin-off of its Nutrition ...
Fintel reports that on 27 October 2026, Argus Research downgraded their outlook for Abbott Laboratories (SWX:ABT) from Buy to ...
A computer vision algorithm reads BinaxNOW COVID-19 rapid antigen test images, estimates viral load against PCR cycle ...
Greg Abbott holds a 65% edge over Gina Hinojosa on Kalshi as an appeals court freezes access to his Elon Musk emails with ...
Live updates from the Mexico City Grand Prix weekend with Kimi Antonelli set to make Formula One history ...
Abbott received U.S. Food and Drug Administration approval for the Amplatzer Paraclose PVL Occluder, the first and only transcatheter device approved in the U.S. that is specifically designed to treat ...
Health and Me on MSN
Cancer drug prices slashed for 543 brands from Nov 9, but a blockbuster drug that treats 21 cancers remains untouched
The NPPA has slashed the prices of cancer drugs from at least 543 brands. The revised prices will be applicable from November ...
What is the Amplatzer Paraclose PVL Occluder? The Amplatzer Paraclose PVL Occluder is the first and only minimally invasive device approved in the U.S. that is designed to close PVL around surgical ...
AbbVie hits all-time highs on strong 2026 guidance, Skyrizi and Rinvoq growth, and leading margins. Click here to read this ...
VTRS, RVTY, ELAN and VCYT have earnings beat signals ahead of Q3 results. Can drug launches, lab spending and cancer tests ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results